Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |